Mechanisms of hematin crystallization and inhibition by the antimalarial drug chloroquine.
about
A Variant PfCRT Isoform Can Contribute to Plasmodium falciparum Resistance to the First-Line Partner Drug PiperaquineSuperparamagnetic Properties of Hemozoin.Microscopy techniques for investigating the control of organic constituents on biomineralizationIdentification and SAR Evaluation of Hemozoin-Inhibiting Benzamides Active against Plasmodium falciparum.Adverse neuropsychiatric effects of antimalarial drugs.Oxidative stress in malaria and artemisinin combination therapy: Pros and Cons.Plasma metabolomics reveals membrane lipids, aspartate/asparagine and nucleotide metabolism pathway differences associated with chloroquine resistance in Plasmodium vivax malariaDetergent-Mediated Formation of β-Hematin: Heme Crystallization Promoted by Detergents Implicates Nanostructure Formation for Use as a Biological Mimic.Quinolines block every step of malaria heme crystal growth.Anti-inflammatory activity of chloroquine and amodiaquine through p21-mediated suppression of T cell proliferation and Th1 cell differentiation.Unraveling heme detoxification in the malaria parasite by in situ correlative X-ray fluorescence microscopy and soft X-ray tomography.Deconstructing Quinoline-Class Antimalarials to Identify Fundamental Physicochemical Properties of Beta-Hematin Crystal Growth Inhibitors.The Effects of Quinoline and Non-Quinoline Inhibitors on the Kinetics of Lipid-Mediated β-Hematin Crystallization.Correlative imaging reveals physiochemical heterogeneity of microcalcifications in human breast carcinomas.Antimalarials inhibit hematin crystallization by unique drug-surface site interactions.Early Onset of Kinetic Roughening due to a Finite Step Width in Hematin Crystallization.Inactivation of Plasmepsin 2 and 3 sensitizes Plasmodium falciparum to the antimalarial drug piperaquine.Chloroquine analogs as antimalarial candidates with potent in vitro and in vivo activity
P2860
Q33654512-F93DB906-28FB-4146-9D6B-A85D245CFF5BQ36910641-BAC00C6F-9ED6-46AF-92D6-87335C870A62Q37042118-900FEBF0-218A-439A-A93D-15A28CF8D410Q37095658-93C6E830-DF27-4E11-A0EA-9E4E7A0757C7Q38808162-CEE01977-E500-4164-930B-5A8BB407FC10Q39280599-8D07ED81-E763-4B7E-8E89-9CE6B69C3DCCQ39543705-3CC19CCB-89DD-42A4-B559-4F38CE67F6D2Q39769655-A1CA83BF-83A5-4EDF-B239-262C60F0D960Q40139919-F9D70E86-AA4C-42CE-A06E-C0037767CA71Q40983378-439B33F7-79E8-4BC9-BD81-9A4FF73D9A02Q41308490-0DE6D3E5-2597-4659-9606-4A3DF4E6CF1FQ41912096-30C5CF9B-EFEC-4BC8-AA47-E74C9F3BFCBAQ41912372-FB061888-0E13-4104-A12B-7696C28B8DB4Q47267540-DF050C4D-7FA3-4343-8A8B-9786C9972961Q47995752-921715C6-4B01-4DD0-8185-D28F009B149FQ50012526-E791F314-88F8-473D-BF01-FB32F538F892Q50028083-7DA8DA72-55CB-4332-A067-1C6B6539D325Q58568501-D4A27558-364F-4514-8471-901B821F1ED0
P2860
Mechanisms of hematin crystallization and inhibition by the antimalarial drug chloroquine.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Mechanisms of hematin crystall ...... antimalarial drug chloroquine.
@ast
Mechanisms of hematin crystall ...... antimalarial drug chloroquine.
@en
type
label
Mechanisms of hematin crystall ...... antimalarial drug chloroquine.
@ast
Mechanisms of hematin crystall ...... antimalarial drug chloroquine.
@en
prefLabel
Mechanisms of hematin crystall ...... antimalarial drug chloroquine.
@ast
Mechanisms of hematin crystall ...... antimalarial drug chloroquine.
@en
P2093
P2860
P356
P1476
Mechanisms of hematin crystall ...... antimalarial drug chloroquine.
@en
P2093
Jeffrey D Rimer
Katy N Olafson
Megan A Ketchum
Peter G Vekilov
P2860
P304
P356
10.1073/PNAS.1501023112
P407
P577
2015-03-23T00:00:00Z